Microscopic polyangiitis-associated interstitial lung disease with acute exacerbation after SARS-CoV-2 infection: a case report and literature review
Modern Rheumatology Case Reports · 06.01.2026 · 10 (1)
DOI: 10.1093/mrcr/rxag035 ↗Kurz gefasst
Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, online erschienen am 15.05.2026. Verfasst von Natsuko Esa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Microscopic Polyangiitis, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Microscopic polyangiitis (MPA) is a type of systemic inflammatory small vessel vasculitis that is frequently accompanied by interstitial lung disease (ILD). Acute exacerbations (AE) of ILD are fatal complications in patients with MPA and can be triggered by various factors, including infections. We report a case of AE of MPA-ILD following severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection. An 81-year-old male with MPA during remission maintenance therapy was hospitalised for Coronavirus disease 2019 pneumonia. Treatment for SARS-CoV-2 infection improved his respiratory symptoms and radiological findings, but his respiratory condition suddenly deteriorated with a high fever on hospital Day 52. Chest high-resolution computed tomography showed diffuse bilateral ground glass opacity, and we diagnosed AE of MPA-ILD. He was refractory to steroid pulse therapy and died on the second day after the onset of AE. Pathologic autopsy revealed hyaline membrane formation over the entire bilateral lobes, consistent with the exudative phase of the diffuse alveolar damage pattern. Our case suggests that persistent immune activation during the post-acute phase of SARS-CoV-2 infection may contribute to delayed AE of MPA-ILD with a diffuse alveolar damage pattern through macrophage-driven lung injury, given that ILD exacerbation occurred approximately 2 months after the onset of Coronavirus disease 2019 pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
- Department of Pathology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
ORCID-Profile: Shogo Matsuda, Takuya Kotani, Tohru Takeuchi
Zitieren
APA
Esa, N., Matsuda, S., Kuwabara, H., Oe, K., Okazaki, A., Suzuka, T., Wada, Y., Shoda, T., Kotani, T., & Takeuchi, T. (2026). Microscopic polyangiitis-associated interstitial lung disease with acute exacerbation after SARS-CoV-2 infection: a case report and literature review. Modern Rheumatology Case Reports, 10(1). https://doi.org/10.1093/mrcr/rxag035
Vancouver
Esa N, Matsuda S, Kuwabara H, Oe K, Okazaki A, Suzuka T, et al. Microscopic polyangiitis-associated interstitial lung disease with acute exacerbation after SARS-CoV-2 infection: a case report and literature review. Modern Rheumatology Case Reports. 2026;10(1). doi:10.1093/mrcr/rxag035
BibTeX
@article{Esa2026,
author = {Esa, Natsuko and Matsuda, Shogo and Kuwabara, Hiroko and Oe, Katsumasa and Okazaki, Ayana and Suzuka, Takayasu and Wada, Yumiko and Shoda, Takeshi and Kotani, Takuya and Takeuchi, Tohru},
title = {Microscopic polyangiitis-associated interstitial lung disease with acute exacerbation after SARS-CoV-2 infection: a case report and literature review},
journal = {Modern Rheumatology Case Reports},
year = {2026},
volume = {10},
number = {1},
doi = {10.1093/mrcr/rxag035}
}
EUVIMED